Kwanso (Hemerocallis fulva)

Kwanso (Hemerocallis fulva) is a Japanese flowering plant containing bioactive compounds that modulate inflammatory pathways through COX-2 and NF-κB inhibition. The flower extract demonstrates significant antioxidant activity with 60% DPPH radical scavenging capacity at 100 µg/mL concentrations.

Origin & History

Kwanso (Hemerocallis fulva var. kwanso) is a perennial herbaceous plant native to East Asia (China, Japan, Korea), commonly known as the orange daylily. The medicinal parts—flowers, leaves, tubers, and roots—are harvested, dried, and traditionally prepared as decoctions, teas, or extracts through hot water steeping or ethanol extraction.

Historical & Cultural Context

Kwanso has been used for centuries in Chinese medicine (since Ming era), Korean, and Ayurvedic systems for anti-inflammatory, diuretic, febrifuge, and sedative effects. In traditional Korean and Japanese medicine, it treats fever, sore throat, and inflammation, while the edible buds are consumed in Korean cuisine as 'surichu namul.' Ayurveda classifies it as sweet/astringent (madhura/kashaya rasa), used to calm pitta and kapha doshas.

Health Benefits

• Anti-inflammatory effects: Animal studies show 35% reduction in paw edema with flower extract through COX-2/NF-κB modulation (preliminary evidence)
• Antioxidant activity: In vitro studies demonstrate 60% DPPH radical scavenging at 100 µg/mL and hydroxyl radical neutralization (preliminary evidence)
• Mild sedative properties: Traditional use supported by potential GABA receptor interaction from anthocyanins; one pilot study reported mild sedative effects from flower-infused honey (traditional/preliminary evidence)
• Hepatoprotective potential: Mouse studies show increased hepatic glutathione levels protecting against acetaminophen-induced injury (preliminary evidence)
• Skin health support: In vitro human fibroblast studies showed 20% collagen increase suggesting wound healing properties (preliminary evidence)

How It Works

Kwanso flower extract contains bioactive compounds that inhibit cyclooxygenase-2 (COX-2) enzyme activity and suppress nuclear factor kappa-B (NF-κB) signaling pathways, reducing pro-inflammatory mediator production. The antioxidant effects occur through direct free radical neutralization, particularly against DPPH and hydroxyl radicals. These mechanisms work synergistically to reduce oxidative stress and inflammatory responses at the cellular level.

Scientific Research

No human clinical trials or RCTs have been conducted on Kwanso (Hemerocallis fulva). Evidence is limited to preclinical studies including a 2021 rat model showing anti-inflammatory effects, 2018 murine trials confirming COX-2/NF-κB modulation, and in vitro antioxidant studies (PMID 35566266) examining leaf flavonoid extracts with optimized extraction methods.

Clinical Summary

Current evidence for Kwanso comes primarily from preliminary animal and in vitro studies rather than human clinical trials. Animal studies demonstrate a 35% reduction in paw edema using flower extract, indicating anti-inflammatory potential. In vitro antioxidant testing shows 60% DPPH radical scavenging at 100 µg/mL concentrations. The evidence base remains limited and requires human clinical trials to establish therapeutic efficacy and optimal dosing protocols.

Nutritional Profile

Per 100 g of fresh daylily flower buds (Hemerocallis fulva): Water ~85–88 g; Energy ~40–50 kcal; Protein ~2.5–3.5 g (notable for a flower, includes free amino acids such as asparagine, glutamic acid, and leucine); Total fat ~0.3–0.5 g; Total carbohydrates ~8–10 g (including dietary fiber ~1.5–2.5 g and soluble sugars ~3–4 g); Ash ~0.8–1.2 g. Micronutrients: Vitamin C ~25–35 mg (moderate source; bioavailability good when consumed fresh, degrades significantly upon drying or prolonged cooking); Vitamin A equivalents (from β-carotene) ~300–500 µg RAE (bioavailability enhanced by co-consumption with dietary fat); Riboflavin (B2) ~0.08–0.12 mg; Niacin (B3) ~0.5–0.8 mg; Iron ~1.5–2.5 mg (non-heme form, bioavailability ~5–12%, improved with vitamin C co-ingestion); Calcium ~40–65 mg; Phosphorus ~55–75 mg; Potassium ~220–300 mg; Zinc ~0.3–0.5 mg; Magnesium ~18–25 mg. Dried flower buds (golden needles / 金针菜) are nutrient-concentrated: Protein ~10–14 g/100 g dry weight; Iron ~6–8 mg/100 g dry weight; Dietary fiber ~7–10 g/100 g dry weight. Bioactive compounds: Total phenolics ~150–350 mg GAE/100 g fresh weight; Total flavonoids ~80–180 mg QE/100 g fresh weight, primarily rutin (~25–60 mg/100 g FW), quercetin (~8–20 mg/100 g FW), kaempferol glycosides (~5–15 mg/100 g FW); Carotenoids include lutein (~1.5–3.0 mg/100 g FW), zeaxanthin (~0.5–1.2 mg/100 g FW), and β-carotene (~2–5 mg/100 g FW) — bioavailability of carotenoids improved ~3–5× when cooked with oil; Anthocyanins present in orange-pigmented petals (cyanidin and pelargonidin glycosides, ~10–30 mg/100 g FW); Polysaccharides ~2–4 g/100 g FW (water-soluble fractions show immunomodulatory activity in vitro); Colchicine-like alkaloids present in raw buds at low concentrations (~0.02–0.05%), largely destroyed by thorough cooking or drying — CAUTION: raw consumption may cause gastrointestinal distress; GABA-related compounds and potential GABA-receptor-active constituents have been detected but not fully quantified. Bioavailability notes: Phenolic compounds show moderate oral bioavailability (~15–30% absorption), enhanced by food matrix disruption during cooking; drying concentrates nutrients but reduces vitamin C by ~60–80%; blanching and sun-drying (traditional golden needle preparation) effectively eliminates colchicine while preserving most mineral and flavonoid content.

Preparation & Dosage

Traditional preparation: 2-3 g dried flowers (approximately 5 petals) steeped in 250 mL hot water for 10-15 minutes, up to 3 cups daily as tea. No clinically studied human dosages are available. Animal studies used oral doses of 400 mg/kg hydroalcoholic extract (related species). Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Quercetin, Green Tea Extract, Turmeric, Ginger, Milk Thistle

Safety & Interactions

Safety data for Kwanso supplementation is limited due to lack of human clinical trials. Traditional use suggests general tolerability, but specific side effects, optimal dosages, and contraindications have not been systematically studied. Potential interactions with anti-inflammatory medications or anticoagulants are unknown due to COX-2 inhibitory activity. Pregnant and breastfeeding women should avoid supplementation until safety data becomes available.